VRTX Stock 3 Insiders at Vertex Pharmaceuticals (VRTX, $445.21) sold 155 shares last week for $66.8K

In the week ending May 20, 2024 three insiders at Vertex Pharmaceuticals (VRTX, $445.21) sold a total of 155 shares for proceeds of $66.8K. Year-to-date, a total of fourteen Vertex Pharmaceuticals officers have sold 73,386 shares worth $29.4M. Here are the insiders making moves:

ARBUCKLE STUART A, EVP, COO – sold 69 shares of VRTX between May 13 - 20, 2024. Total $29.7K.

ALTSHULER DAVID, EVP, Chief Scientific Officer – sold 54 shares of VRTX between May 13 - 20, 2024. Total $23.3K.

SACHDEV AMIT, EVP Chief Patient & Ext Af Off – sold 32 shares of VRTX between May 13 - 20, 2024. Total $13.8K.